Jefferies analyst Michael Yee previews the year ahead, the outlook for M&A, and dives into top picks
- blonca9
- Jan 16, 2024
- 1 min read
Michael Yee shares takeaways from last week's conference in San Francisco and highlights his top names to watch.
Also look for unique social pages for BiotechTV U.
Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.
Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.